CPI-637
CPI-637 is a selective and potent CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 μM, 0.051 μM and 11.0 μM for CBP, EP300 and BRD4 BD-1, respectively, and an EC50 of 0.3 μM for CBP[1].
Product Specifications
CAS Number
[1884712-47-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Epigenetic Reader Domain; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CPI-637.html
Purity
99.94
Solubility
DMSO : 9.62 mg/mL (ultrasonic)
Smiles
O=C1NC2=CC=CC(C3=CC4=C(N(C)N=C4C5=CN(C)N=C5)C=C3)=C2N[C@H](C)C1
Molecular Formula
C22H22N6O
Molecular Weight
386.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Taylor AM, et al. Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637) . ACS Med Chem Lett. 2016 Mar 15;7 (5) :531-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD4; CBP/p300; TIP60
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15378488 1 Vial
Lentiviral human MAP1B sgRNA gene knockout kit - Lentiviral human MAP1B sgRNA gene knockout kit (plasmid)
Ask
View Details 